810223P

C12-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand

• Synonym(e): N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1′-sphingosine
• Empirische Formel (Hill-System): C₄₂H₇₁N₅O₁₁
• CAS-Nummer: 474943-01-6
• Molekulargewicht: 822.04
• MDL-Nummer: MFCD22570234
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 1 mg (810223P-1MG); pkg of 1 × 250 μg (810223P-250ug)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Anwendung

C12-NBD Glucosyl Ceramide is suitable for liposome preparation.

Biochem./physiol. Wirkung

Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.

Verpackung

5 mL Amber Glass Screw Cap Vial (810223P-1MG)

5 mL Amber Glass Screw Cap Vial (810223P-250ug)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable